
UNIVERSAL TECHNICAL INSTITUTE, INC.
Q4 FY2026 FINANCIAL SUPPLEMENT
Consolidated Q4 2026 Highlights$235.9 million $897.0 million
$18.0 million $33.6 million
$42.5 million $102.0 million
$0.32 $0.60
Note: See Company Press Release and Investor Presentation dated November 18, 2026 for more details on guidance, including non-GAAP reconciliations.
Revenue increased 6.0% to $235.9 million. The Concorde division contributed $82.2 million (5.7% YoY), and the UTI division contributed $153.6 million (6.2% YoY growth).
Revenue
Revenue
FY 2026
Q4 2026
Total Full-Time Active Students grew 6.3% year-over-year to 26,630.
Net Income Net Income
Net Income was $18.0 million or $0.32 per diluted share.
Adjusted EBITDA Adjusted EBITDA
Baseline adjusted EBITDA was $49.5 million. Including $7.0 million in net growth investments, reported adjusted EBITDA was $42.5 million.
Diluted Earnings Per Diluted Earnings Per
Share Share
Total available liquidity of $320.8 million, including cash, cash equivalents, and remaining capacity on our revolving credit facility-ample reserves for any potential working capital needs or new opportunities that may arise for the Company.
The Company concluded the fiscal year well-positioned and remains confident in delivering its 5-year strategic targets of over $1.2 billion in Revenue and Adjusted EBITDA approaching $220M by FY2029.
Consolidated Q4 2026 Summary Results($ in millions)
3 Mos. 9/30/26 | 3 Mos. 9/30/25 | YoY Change | 12 Mos. 9/30/26 | 12 Mos. 9/30/25 | YoY Change | |
Revenues | $235.9 | $222.4 | 6.0% | $897.0 | $835.6 | 7.4% |
Operating expenses | $209.6 | $197.5 | 6.2% | $851.5 | $752.1 | 13.2% |
Educational services and facilities | $124.1 | $112.3 | 10.5% | $470.3 | $420.5 | 11.8% |
Selling, general and administrative | $85.5 | $85.2 | 0.4% | $381.2 | $331.7 | 14.9% |
Income from operations | $26.3 | $25.0 | 5.1% | $45.5 | $83.5 | (45.4)% |
Total other (expense) income, net | $(0.2) | $0.6 | (130.0)% | $0.3 | $0.8 | (68.8)% |
Income tax expense | $(8.1) | $(6.8) | 18.4% | $(12.2) | $(21.3) | (42.6)% |
Net income | $18.0 | $18.8 | (3.8)% | $33.6 | $63.0 | (46.7)% |
Adjusted EBITDA(1) | $42.5 | $36.8 | 15.5% | $102.0 | $126.5 | (19.3)% |
Operating cash flow | $76.8 | $57.1 | 34.5% | $94.2 | $97.3 | (3.2)% |
Adjusted free cash flow(1) | $53.0 | $41.0 | 29.2% | $(12.6) | $56.0 | (122.5)% |
Purchase of property and equipment | $25.5 | $16.5 | 54.9% | $106.4 | $42.0 | 153.5% |
Capitalized costs for intangible assets | $2.0 | $- | -% | $6.5 | $- | -% |
1. For a detailed reconciliation of Non-GAAP measures, see slides 14-18.
Consolidated Statements of Operations Trend($ in thousands, except EPS)
12 Mos. 9/30/26 | 3 Mos. 9/30/26 | 3 Mos. 6/30/26 | 3 Mos. 3/31/26 | 3 Mos. 12/31/25 | 12 Mos. 9/30/25 | 3 Mos. 9/30/25 | 3 Mos. 6/30/25 | 3 Mos. 3/31/25 | 3 Mos. 12/31/24 | |
Revenues | $ 897,036 | $ 235,883 | $ 218,907 | $ 221,402 | $ 220,844 | $ 835,616 | $ 222,442 | $ 204,298 | $ 207,447 | $ 201,429 |
Operating expenses: | ||||||||||
Educational services and facilities | 470,295 | 124,084 | 118,334 | 117,429 | 110,448 | 420,491 | 112,258 | 105,604 | 102,488 | 100,141 |
Selling, general and administrative | 381,205 | 85,534 97,328 103,634 94,709 | 331,656 | 85,198 84,542 88,106 73,810 | ||||||
Total operating expenses | 851,500 | 209,618 215,662 221,063 205,157 | 752,147 | 197,456 190,146 190,594 173,951 | ||||||
Income from operations | 45,536 | 26,265 | 3,245 | 339 | 15,687 | 83,469 | 24,986 | 14,152 | 16,853 | 27,478 |
Total other (expense) income, net | 251 | (172) | (146) | 44 | 525 | 805 | 573 | 200 | (19) | 51 |
Income tax (expense) benefit | (12,211) | (8,056) (820) 50 (3,385) | (21,256) | (6,803) (3,689) (5,388) (5,376) | ||||||
Net Income | 33,576 | 18,037 2,279 433 12,827 | 63,018 | 18,756 10,663 11,446 22,153 | ||||||
Net income per share, diluted | $ 0.60 | $ 0.32 | $ 0.04 | $ 0.01 | $ 0.23 | $ 1.13 | $ 0.34 | $ 0.19 | $ 0.21 | $ 0.40 |
EBITDA(1) | $ 86,025 | $ 38,362 | $ 13,758 | $ 9,361 | $ 24,542 | $ 116,692 | $ 33,634 | $ 22,616 | $ 25,000 | $ 35,442 |
Total Shares Outstanding (Period End) | 55,099 | 55,099 | 55,095 | 55,061 | 55,014 | 54,430 | 54,430 | 54,424 | 54,406 | 54,366 |
Weighted Average Diluted Shares Outstanding | 55,802 | 55,808 | 55,935 | 55,730 | 55,744 | 55,615 | 55,728 | 55,635 | 55,442 | 55,406 |
For a detailed reconciliation of Non-GAAP measures, see slides 14-18.
Consolidated Results of Operations Trend Percent of Revenue12 Mos.
9/30/26
3 Mos.
9/30/26
3 Mos.
6/30/26
3 Mos.
3/31/26
3 Mos.
12/31/25
12 Mos.
9/30/25
3 Mos.
9/30/25
3 Mos.
6/30/25
3 Mos.
3/31/25
3 Mos.
12/31/24
Revenues
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
Operating Expenses:
Educational services and facilities
52.4%
52.6%
54.1%
53.0%
50.0%
50.3%
50.5%
51.7%
49.4%
49.8%
Selling, general and administrative
42.5%
36.3%
44.5%
46.8%
42.9%
39.7%
38.3%
41.4%
42.5%
36.6%
Total operating expenses
94.9%
88.9%
98.6%
99.8%
92.9%
90.0%
88.8%
93.1%
91.9%
86.4%
Income from operations
5.1%
11.1%
1.5%
0.2%
7.1%
10.0%
11.2%
6.9%
8.1%
13.6%
Total other (expense) income, net
-%
(0.1)%
(0.2)%
-%
0.2%
0.1%
0.3%
0.1%
-%
0.1%
Income tax (expense) benefit
(1.4)%
(3.4)%
(0.4)%
0.0%
(1.5)%
(2.5)%
(3.1)%
(1.8)%
(2.6)%
(2.7)%
Net Income
3.7%
7.6%
1.0%
0.2%
5.8%
7.6%
8.4%
5.2%
5.5%
11.0%
EBITDA(1)
9.6%
16.3%
6.3%
4.2%
11.1%
14.0%
15.1%
11.1%
12.1%
17.6%
For a detailed reconciliation of Non-GAAP measures, see slides 14-18.
($ in millions, except revenue per student amounts)
3 Mos. 9/30/26 UTI | 3 Mos. 6/30/26 UTI | 3 Mos. 3/31/26 UTI | 3 Mos. 12/31/25 UTI | 3 Mos. 9/30/25 UTI | 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 9/30/26 6/30/26 3/31/26 12/31/25 9/30/25 Concorde Concorde Concorde Concorde Concorde | |||||
New student starts | 7,339 | 3,491 | 4,110 | 2,893 | 7,166 | 5,174 | 2,851 | 3,459 | 2,556 | 4,943 |
Y/Y growth/(decline) | 2.4% | 23.4% | 14.5% | 5.1% | 1.4% | 4.7% | (1.4)% | 13.1% | (0.2)% | 11.7% |
Average full-time active students | 15,988 | 14,767 | 15,556 | 16,347 | 15,207 | 10,642 | 10,364 | 10,829 | 10,511 | 9,842 |
Y/Y growth/(decline) | 5.1% | 4.0% | 5.3% | 5.7% | 8.1% | 8.1% | 8.5% | 10.2% | 9.5% | 8.0% |
Revenue per student | $9,600 | $9,300 | $9,200 | $8,700 | $9,500 | $7,700 | $7,800 | $7,300 | $7,400 | $7,900 |
Y/Y growth/(decline) | 1.1% | 0.0% | 1.1% | 2.4% | 2.2% | (2.5)% | 2.6% | (1.4)% | 1.4% | 9.7% |
Revenues | $153.6 | $138.0 | $142.7 | $142.8 | $144.6 | $82.2 | $80.9 | $78.7 | $78.0 | $77.8 |
Y/Y growth/(decline) | 6.2% | 4.9% | 6.3% | 8.6% | 10.8% | 5.7% | 11.1% | 7.5% | 11.4% | 18.2% |
Income from operations | $38.2 | $22.6 | $22.8 | $33.1 | $39.6 | $12.2 | $13.0 | $10.1 | $13.3 | $13.3 |
Margin | 24.9% | 16.4% | 16.0% | 23.2% | 27.4% | 14.8% | 16.1% | 12.8% | 17.1% | 17.1% |
Adjusted EBITDA(1) | $32.4 | $14.3 | $11.3 | $22.7 | $30.9 | $8.5 | $6.4 | $2.2 | $6.2 | $7.3 |
Adjusted EBITDA margin | 21.1% | 10.3% | 7.9% | 15.9% | 21.4% | 10.3% | 7.9% | 2.7% | 7.9% | 9.4% |
1. For a detailed reconciliation of Non-GAAP measures, see slides 14-18.
Segment Results of Operations: Fourth Quarter($ in thousands)
3 Mos. | 3 Mos. | 3 Mos. | 3 Mos. | 3 Mos. | 3 Mos. | |||||||
9/30/26 | 9/30/26 | 9/30/26 | 9/30/25 | 9/30/25 | 9/30/25 | |||||||
UTI | Concorde | Total | UTI | Concorde | Total | |||||||
Revenues | $ 153,648 | $ 82,235 | $ 235,883 | $ 144,648 | $ 77,794 | $ 222,442 | ||||||
Compensation and benefits | 54,300 | 35,077 | 89,377 | 51,907 | 33,849 | 85,756 | ||||||
Advertising | 14,602 | 8,999 | 23,601 | 12,718 | 7,784 | 20,502 | ||||||
Occupancy | 11,414 | 6,910 | 18,324 | 11,621 | 6,563 | 18,184 | ||||||
Student related | 17,149 | 7,721 | 24,870 | 11,734 | 7,074 | 18,808 | ||||||
General operations | 6,336 | 5,994 | 12,330 | 6,723 | 4,934 | 11,657 | ||||||
Professional and contract services | 2,181 | 1,039 | 3,220 | 2,536 | 1,330 | 3,866 | ||||||
Depreciation and amortization | 8,199 | 3,476 | 11,675 | 6,138 | 2,055 | 8,193 | ||||||
Other expenses | 1,228 | 797 | 2,025 | 1,646 | 887 | 2,533 | ||||||
Total operating expenses | $ 115,409 | $ 70,013 | $ 185,422 | $ 105,023 | $ 64,476 | $ 169,499 | ||||||
Corporate costs | - | - | 24,196 | - | - | 27,957 | ||||||
Income from operations | 38,239 | 12,222 | 26,265 | 39,625 | 13,318 | 24,986 | ||||||
Net income | 23,665 | 4,765 | 18,037 | 23,418 | 5,000 | 18,756 | ||||||
EBITDA(1) | 32,663 | 8,283 | 38,362 | 30,374 | 7,068 | 33,634 | ||||||
Adjusted EBITDA(1) | 32,446 | 8,536 | 42,490 | 30,856 | 7,301 | 36,779 | ||||||
Adjusted EBITDA margin | 21.1% | 10.4% | 18.0% | 21.3% | 9.4% | 16.5% | ||||||
1. For a detailed reconciliation of Non-GAAP measures, see slides 14-18. | ||||||||||||
($ in thousands)
12 Mos. | 12 Mos. | 12 Mos. | 12 Mos. | 12 Mos. | 12 Mos. | |||||||
9/30/26 | 9/30/26 | 9/30/26 | 9/30/25 | 9/30/25 | 9/30/25 | |||||||
UTI | Concorde | Total | UTI | Concorde | Total | |||||||
Revenues | $ 577,225 | $ 319,811 | $ 897,036 | $ 541,815 | $ 293,801 | $ 835,616 | ||||||
Compensation and benefits | 224,003 | 144,726 | 368,729 | 205,031 | 131,978 | 337,009 | ||||||
Advertising | 67,815 | 37,988 | 105,803 | 57,754 | 30,575 | 88,329 | ||||||
Occupancy | 43,449 | 26,165 | 69,614 | 39,866 | 24,769 | 64,635 | ||||||
Student related | 51,797 | 24,309 | 76,106 | 38,245 | 24,084 | 62,329 | ||||||
General operations | 28,153 | 19,527 | 47,680 | 20,702 | 17,919 | 38,621 | ||||||
Professional and contract services | 9,697 | 4,895 | 14,592 | 9,866 | 5,198 | 15,064 | ||||||
Depreciation and amortization | 28,525 | 10,468 | 38,993 | 24,086 | 7,554 | 31,640 | ||||||
Other expenses | 7,089 | 3,142 | 10,231 | 6,504 | 3,665 | 10,169 | ||||||
Total operating expenses | $ 460,528 | $ 271,220 | $ 731,748 | $ 402,054 | $ 245,742 | $ 647,796 | ||||||
Corporate costs | - | - | 119,752 | - | - | 104,351 | ||||||
Income from operations | 116,697 | 48,591 | 45,536 | 139,761 | 48,059 | 83,469 | ||||||
Net income | 47,087 | 11,447 | 33,576 | 77,731 | 16,593 | 63,018 | ||||||
EBITDA(1) | 78,837 | 22,036 | 86,025 | 106,379 | 24,274 | 116,692 | ||||||
Adjusted EBITDA(1) | 80,786 | 23,266 | 102,031 | 108,274 | 24,983 | 126,455 | ||||||
Adjusted EBITDA margin | 14.0% | 7.3% | 11.4% | 20.0% | 8.5% | 15.1% | ||||||
1. For a detailed reconciliation of Non-GAAP measures, see slides 14-18. | ||||||||||||
($ in thousands)
127,361
144,212 $
$
Cash & cash equivalents
9/30/25
9/30/26
At:
97,330
94,232 $
$
Net cash provided by operating activities
12 Mos.
9/30/25
12 Mos.
9/30/26
Short-term investments | 26,570 | 41,784 | Purchase of property and equipment | (106,429) | (41,978) | |
Total current assets | 253,035 | 246,632 | Capitalized costs for intangible assets | (6,514) | - | |
PP&E (net) | 357,154 | 285,852 | Purchase of investments | (57,347) | (68,371) |
Goodwill and Intangible assets, net 55,248 45,811
Right-of-use assets for operating leases
188,005
178,861
Notes receivable, less current portion 47,484 41,109 Total assets 923,478 826,139Long term debt, current portion 3,039 2,865
Operating lease liability, current portion 17,524 16,967 Total current liabilities 232,668 229,671
Net cash used in investing activities (93,916) (87,879)Proceeds from sale of investments | 31,668 | - |
Proceeds received upon maturity of investments | 44,670 | 22,301 |
Payment of payroll taxes on stock-based compensation through shares withheld
(8,772)
(4,755)
Operating lease liability | 192,848 | 174,838 | ||||
Long-term debt | 111,287 | 84,234 | Change in cash and restricted cash | 18,679 | (33,342) | |
Total liabilities | 559,337 | 498,029 | Ending balance of cash and restricted cash | $ 152,809 | $ 134,130 | |
Stockholders' equity | 364,141 | 328,110 | ||||
Total liabilities & equity | $ 923,478 | $ 826,139 | ||||
Net cash provided by (used in) financing activities 18,363 (42,793)
Earnings Per Share Trend and Guidance($ in thousands, except EPS)
Guidance Fiscal 2027 Midpoint | Actual 12 Mos. 9/30/26 | Actual 3 Mos. 9/30/26 | Actual 3 Mos. 6/30/26 | Actual 3 Mos. 3/31/26 | Actual 3 Mos. 12/31/25 | Actual 12 Mos. 9/30/25 | Actual 3 Mos. 9/30/25 | Actual 3 Mos. 6/30/25 | Actual 3 Mos. 3/31/25 | Actual 3 Mos. 12/31/24 | |
Net Income | ~$0-5,000 | $ 33,576 | $ 18,037 | $ 2,279 | $ 433 | $ 12,827 | $ 63,018 | $ 18,756 | $ 10,663 | $ 11,446 | $ 22,153 |
Weighted average basic shares outstanding | ~55,400 | 54,943 | 55,096 | 55,075 | 55,033 | 54,570 | 54,301 | 54,425 | 54,412 | 54,383 | 53,987 |
Basic income per common share | ~$0.00-0.09 | $ 0.61 | $ 0.33 | $ 0.04 | $ 0.01 | $ 0.24 | $ 1.16 | $ 0.34 | $ 0.20 | $ 0.21 | $ 0.41 |
Weighted average basic shares outstanding | ~55,400 | 54,943 | 55,096 | 55,075 | 55,033 | 54,570 | 54,301 | 54,425 | 54,412 | 54,383 | 53,987 |
Dilutive effect related to employee stock plans | ~900 | 859 | 712 | 860 | 697 | 1,175 | 1,314 | 1,303 | 1,223 | 1,059 | 1,419 |
Weighted average diluted shares outstanding | ~56,300 | 55,802 | 55,808 | 55,935 | 55,730 | 55,745 | 55,615 | 55,728 | 55,635 | 55,442 | 55,406 |
Diluted income per common share | ~$0.00-0.09 | $ 0.60 | $ 0.32 | $ 0.04 | $ 0.01 | $ 0.23 | $ 1.13 | $ 0.34 | $ 0.19 | $ 0.21 | $ 0.40 |
Term Loan: Avondale Campus
Debt as of 09/30/2026
LTM EBITDA $102.0M
Original Note Amount $31.2M
Inception Date 5/12/2021
$114.3M
Total Debt, net
Leverage as of 09/30/2026
Maturity 7 years
1.12x
(0.55)x
Gross Leverage Ratio
Net Leverage Ratio
$170.8M
Cash, Cash Equivalents, and Short-Term Investments
Current Note Balance $26.6M
Term Loan: Lisle CampusOriginal Note Amount $38.0M
LTM EBITDA - FY 2027 Guidance Midpoint ~$103M
Inception Date 4/14/2022Rate** Fixed/Floating
~$111M
Total Debt, net (Projected)
Proforma Leverage 09/30/2027
Current Note Balance $35.1M
Revolving Credit Facility
~1.08x
~(0.57)x
Gross Leverage Ratio
Net Leverage Ratio
Cash, Cash Equivalents, and Short-Term Investments (Projected) ~$170M
Total Capacity $200.0M
Inception Date 8/12/2026
9/30/2027 proforma leverage calculation is based upon midpoint of the adjusted EBITDA guidance range and projected year-end cash balance, both of which will depend on actual company performance. For a detailed reconciliation of Non-GAAP measures, see slides 14-18.
Note: Use of the revolver will continue to be evaluated throughout the year and used as needed to support working capital needs and satisfy regulatory requirements &/or debt covenants. Any change to the outstanding revolver balance would affect gross leverage but have no impact on net leverage.
Rate*** FloatingMaturity 5 years
Current Loan Balance $50.0M
*Avondale rate is 50% fixed at 1.45% + 50% Floating @ SOFR plus 2% Margin and a tranche adjustment of 0.046%
**Lisle rate is 50% fixed at 4.69% + 50% Floating @ SOFR plus 2% Margin
***Revolver rate is term SOFR plus 1.50% to 2.25% margin based on UTI's total leverage
Use of Non-GAAP Financial InformationIn addition to disclosing financial results that are determined in accordance with U.S. generally accepted accounting principles ("GAAP"), the Company also discloses certain non-GAAP financial information in this press release and may similarly disclose non-GAAP financial information on the related conference call. These financial measures are not recognized measures under GAAP and are not intended to be and should not be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. The Company discloses these non-GAAP financial measures because it believes that they provide investors an additional analytical tool to clarify its results of operations and identify underlying trends. Additionally, the Company believes that these measures may also help investors compare its performance on a consistent basis across time periods. Additional details on our non-GAAP measures and the tables reconciling these measures to the most directly comparable GAAP measure are provided below.
Management utilizes adjusted figures as performance measures internally for operating decisions, strategic planning, annual budgeting and forecasting. For the periods presented, our adjustments for items that management does not consider to be normal recurring operations include:
Acquisition-related costs: We have excluded costs associated with both potential and announced acquisitions to allow for comparable financial results to historical operations and forward-looking guidance.
Integration-related costs for completed acquisitions: We have excluded integration costs related to business structure realignment and new programs for recent acquisitions to allow for comparable financial results to historical operations and forward-looking guidance. In addition, the nature and amount of such charges vary significantly based on the size and timing of the programs. By excluding the referenced expenses from our non-GAAP financial measures, our management is able to further evaluate our ability to utilize existing assets and estimate their long-term value. Furthermore, our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.
Restructuring costs: In May 2026, management approved and implemented phase I of a multi-phase restructuring plan across all segments to simplify how we operate, improve student acquisition and better align our resources behind the highest-return opportunities across the business. Phase II was rolled out in July 2026 and is expected to span over the next three years as part of our continued focus on optimization and to better align resources to support our overall growth strategy. In December 2023, we announced plans to consolidate the two Houston, Texas campus locations to align the curriculum, student facing systems, and support services to better serve students seeking careers in in-demand fields. As part of the transition, the MIAT Houston campus began a phased teach-out in May 2024 and began operating under the UTI brand.
To obtain a complete understanding of our performance, these measures should be examined in connection with net income (loss) and net cash provided by (used in) operating activities, determined in accordance with GAAP, as presented in the financial statements and notes thereto included in the annual and quarterly filings with the Securities and Exchange Commission ("SEC"). Because the items excluded from these non-GAAP measures are significant components in understanding and assessing our financial performance under GAAP, these measures should not be considered to be an alternative to net income (loss) or net cash provided by (used in) operating activities as a measure of our operating performance or liquidity. Exclusion of items in the non-GAAP presentation should not be construed as an inference that these items are unusual, infrequent or non-recurring. Other companies, including other companies in the education industry, may define and calculate non-GAAP financial measures differently than we do, limiting their usefulness as a comparative measure across similarly titled performance measures presented by other companies. A reconciliation of the historical non-GAAP financial measures to the most directly comparable GAAP measures is provided below and investors are encouraged to review the reconciliations.
Information reconciling forward-looking adjusted EBITDA and adjusted free cash flow to the most directly comparable GAAP financial measure is unavailable to the company without unreasonable effort. The company is not able to provide a quantitative reconciliation of forward-looking adjusted EBITDA or adjusted free cash flow to the most directly comparable GAAP financial measure because certain items required for such reconciliation are uncertain, outside of the company's control and/or cannot be reasonably predicted, including but not limited to the provision for (benefit from) income taxes. Preparation of such reconciliation would require a forward-looking statement of income and statement of cash flows prepared in accordance with GAAP, and such forward-looking financial statements are unavailable to the company without unreasonable effort.
Consolidated Adjusted EBITDA Reconciliation($ in thousands)
QUARTER-TO-DATE 12 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 12 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 9/30/26 9/30/26 6/30/26 3/31/26 12/31/25 9/30/25 9/30/25 6/30/25 3/31/25 12/31/24
Net income, as reported
$ 33,576
$ 18,037 $ 2,279 $ 433 $ 12,827
$ 63,018
$ 18,756 $ 10,663 $ 11,446 $ 22,153
Interest (income) expense, net
(166)
227 249 (67) (575)
(540)
(431) (51) 28 (86)
Income tax expense (benefit)
12,211
8,056 820 (50) 3,385
21,256
6,803 3,689 5,388 5,376
Depreciation and amortization
40,404
12,042 10,410 9,045 8,905
32,958
8,506 8,315 8,138 7,999
EBITDA $ 86,025 $ 38,362 $ 13,758 $ 9,361 $ 24,542 $ 116,692 $ 33,634 $ 22,616 $ 25,000 $ 35,442
Stock-based compensation expense
11,105
1,679 2,970 3,901 2,555
9,151
2,749 2,658 3,024 720
Restructuring costs(1)
2,800
1,704 1,096 - -
43
- - - 43
Integration related costs for completed acquisitions(2)
2,101
745 421 884 51
(304)
396 - - (700)
Acquisition related costs(3)
-
- - - -
873
- - 873 -
Adjusted EBITDA, non-GAAP $ 102,031 $ 42,490 $ 18,245 $ 14,146 $ 27,148 $ 126,455 $ 36,779 $ 25,274 $ 28,897 $ 35,505
In May 2026 and July 2026, management approved and implemented phase I and II of a multi-phase restructuring plan across all segments to simplify how we operate, improve student acquisition and better align our resources behind the highest-return opportunities across the business. In December 2023, the Company announced plans to consolidate its MIAT-Houston and UTI-Houston operations beginning in fiscal 2024 which was completed in Q1 fiscal 2025.
In fiscal 2025, the Company received $0.7 million in funds in final settlement of the outstanding escrow accounts affiliated with the purchase of Concorde on December 1, 2022. This is offset by additional integration costs incurred during the year.
Costs related to both announced and potential acquisition targets.
($ in thousands)
YEAR-TO-DATE | 12 Mos. 9/30/26 | 9 Mos. 6/30/26 | 6 Mos. 3 Mos. 12 Mos. 9 Mos. 6 Mos. 3 Mos. 3/31/26 12/31/25 9/30/25 6/30/25 3/31/25 12/31/24 | |||||
Net income, as reported | $ 33,576 | $ 15,539 $ 13,260 $ | 12,827 | $ 63,018 | $ 44,262 $ 33,599 $ | 22,153 | ||
Interest (income) expense, net | (166) | (393) (642) | (575) | (540) | (109) (58) | (86) | ||
Income tax expense | 12,211 | 4,155 3,335 | 3,385 | 21,256 | 14,453 10,764 | 5,376 | ||
Depreciation and amortization | 40,404 | 28,361 17,950 | 8,905 | 32,958 | 24,452 16,137 | 7,999 | ||
EBITDA | $ 86,025 $ 47,662 $ 33,903 $ | 24,542 $ 116,692 $ 83,058 $ 60,442 $ | 35,442 | |||||
Stock-based compensation expense | 11,105 | 9,426 6,456 | 2,555 | 9,151 | 6,402 3,744 | 720 | ||
Restructuring costs(1) | 2,800 | 1,096 | - | - | 43 | 43 43 | 43 | |
Integration related costs for completed acquisitions(2) | 2,101 | 1,356 | 935 | 51 | (304) | (700) (700) | (700) | |
Acquisition related costs(3) | - | - | - | - | 873 | 873 873 | - | |
Adjusted EBITDA, non-GAAP | $ 102,031 $ | 59,540 $ | 41,294 $ | 27,148 $ 126,455 $ 89,676 $ 64,402 $ | 35,505 | |||
In May 2026 and July 2026, management approved and implemented phase I and II of a multi-phase restructuring plan across all segments to simplify how we operate, improve student acquisition and better align our resources behind the highest-return opportunities across the business. In December 2023, the Company announced plans to consolidate its MIAT-Houston and UTI-Houston operations beginning in fiscal 2024 which was completed in Q1 fiscal 2025.
In fiscal 2025, the Company received $0.7 million in funds in final settlement of the outstanding escrow accounts affiliated with the purchase of Concorde on December 1, 2022. This is offset by additional integration costs incurred during the year.
Costs related to both announced and potential acquisition targets.
Adjusted EBITDA Reconciliation By Segment($ in thousands)
QUARTER-TO-DATE 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 3 Mos. 9/30/26 9/30/25 9/30/26 9/30/25 9/30/26 9/30/25
UTI UTI Concorde Concorde Corporate Corporate
Net income (loss), as reported
$ 23,665 $
23,418 $
4,765 $
5,000 $
(10,393) $
(9,662)
Interest expense (income), net
799
797
42
13
(614)
(1,241)
Income tax expense
-
-
-
-
8,056
6,803
Depreciation and amortization
8,199
6,159
3,476
2,055
367
292
EBITDA
$ 32,663
$ 30,374
$ 8,283
$ 7,068
$ (2,584) $
(3,808)
Stock-based compensation expense
(217)
482
253
233
1,643
2,034
Restructuring costs(1)
-
-
-
-
1,704
-
Integration related costs for completed acquisitions
-
-
-
-
745
396
Adjusted EBITDA, non-GAAP
$ 32,446
$ 30,856
$ 8,536
$ 7,301
$ 1,508 $
(1,378)
In May 2026 and July 2026, management approved and implemented phase I and II of a multi-phase restructuring plan across all segments to simplify how we operate, improve student acquisition and better align our resources behind the highest-return opportunities across the business. In December 2023, the Company announced plans to consolidate its MIAT-Houston and UTI-Houston operations beginning in fiscal 2024 which was completed in Q1 fiscal 2025.
($ in thousands)
YEAR-TO-DATE | 12 Mos. 9/30/26 | 12 Mos. 9/30/25 | 12 Mos. 9/30/26 | 12 Mos. 9/30/25 | 12 Mos. 9/30/26 | 12 Mos. 9/30/25 |
UTI UTI Concorde Concorde Corporate Corporate | ||||||
Net income (loss), as reported | $ 47,087 $ | 77,731 $ | 11,447 $ | 16,593 $ | (24,958) $ | (31,306) |
Interest expense (income), net | 3,225 | 4,479 | 121 | 127 | (3,512) | (5,146) |
Income tax expense | - | - | - | - | 12,211 | 21,256 |
Depreciation and amortization | 28,525 | 24,169 | 10,468 | 7,554 | 1,411 | 1,235 |
EBITDA | $ 78,837 | $ 106,379 | $ 22,036 | $ 24,274 | $ (14,848) $ | (13,961) |
Stock-based compensation expense | 1,237 | 1,852 | 1,000 | 709 | 8,868 | 6,590 |
Restructuring costs(1) | 712 | 43 | 230 | - | 1,858 | - |
Integration related costs for completed acquisitions(2) | - | - | - | - | 2,101 | (304) |
Acquisition related costs(3) | - | - | - | - | - | 873 |
Adjusted EBITDA, non-GAAP | $ 80,786 | $ 108,274 | $ 23,266 | $ 24,983 | $ (2,021) $ | (6,802) |
In May 2026 and July 2026, management approved and implemented phase I and II of a multi-phase restructuring plan across all segments to simplify how we operate, improve student acquisition and better align our resources behind the highest-return opportunities across the business. In December 2023, the Company announced plans to consolidate its MIAT-Houston and UTI-Houston operations beginning in fiscal 2024 which was completed in Q1 fiscal 2025.
In fiscal 2025, the Company received $0.7 million in funds in final settlement of the outstanding escrow accounts affiliated with the purchase of Concorde on December 1, 2022. This is offset by additional integration costs incurred during the year.
Costs related to both announced and potential acquisition targets.
($ in thousands)
12 Mos. 9/30/26 | 12 Mos. 9/30/25 | |
Cash flow provided by operating activities, as reported | $94,232 | $97,330 |
Purchase of property and equipment | (106,429) | (41,978) |
Capitalized costs for intangible assets | (6,514) | - |
Free cash flow, non-GAAP | $(18,711) | $55,352 |
Adjustments: | ||
Cash outflow (inflow) for integration-related costs for completed acquisitions(1) | 2,672 | (304) |
Cash outflow for integration-related property, equipment and intangibles | 2,113 | - |
Cash outflow for restructuring costs(2) | 1,336 | 59 |
Cash outflow for acquisition-related costs(3) | - | 873 |
Adjusted free cash flow, non-GAAP | $(12,590) | $55,980 |
In fiscal 2025, the Company received $0.7 million in funds in final settlement of the outstanding escrow accounts affiliated with the purchase of Concorde on December 1, 2022. This is offset by additional integration costs incurred during the year.
In May 2026 and July 2026, management approved and implemented phase I and II of a multi-phase restructuring plan across all segments to simplify how we operate, improve student acquisition and better align our resources behind the highest-return opportunities across the business. In December 2023, the Company announced plans to consolidate its MIAT-Houston and UTI-Houston operations beginning in fiscal 2024 which was completed in Q1 fiscal 2025.
Costs related to both announced and potential acquisition targets.
| Attention: This is an excerpt of the original content. To continue reading it, access the original document here. |
